[Glaucoma due to elevated episcleral venous pressure].

Ophthalmologe

Klinik und Poliklinik für Augenheilkunde, Klinikum der Universität Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Deutschland.

Published: May 2019

Background: Glaucoma due to elevated episcleral venous pressure is a rare and difficult to treat form of secondary open angle glaucoma.

Objective: The pathophysiology, clinical findings, differential diagnosis and treatment options are discussed. Radius-Maumenee syndrome, Sturge-Weber syndrome and carotid-cavernous sinus fistulas are covered in particular.

Material And Methods: A literature search was conducted in the PubMed database.

Results: In the course of the diagnostics potentially severe diseases, such as carotid-cavernous sinus fistulas have to be ruled out. Treatment is based on the therapy of the underlying disease. Anti-glaucomatous medicinal treatment is often insufficient. In the case of surgery the increased risk for severe complications has to be taken into account. A variety of different surgical approaches have been reported in a number of small case series.

Conclusion: Glaucoma due to elevated episcleral venous pressure can be idiopathic or secondary to another underlying disease. Although rare it should always be considered in the differential diagnosis. Treatment is challenging because of an increased risk for severe complications.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00347-018-0828-4DOI Listing

Publication Analysis

Top Keywords

elevated episcleral
12
episcleral venous
12
glaucoma elevated
8
venous pressure
8
differential diagnosis
8
diagnosis treatment
8
carotid-cavernous sinus
8
sinus fistulas
8
underlying disease
8
increased risk
8

Similar Publications

Purpose: Idiopathic elevated episcleral venous pressure (IEEVP) or Radius-Maumenee syndrome (RMS) is a rare disease without any identified underlying cause. An increasing episcleral venous pressure (EVP) leads to raised intraocular pressure (IOP) and consequently glaucomatous damage of the optic nerve. The objective of this paper is to report this rare condition as well as its clinical management.

View Article and Find Full Text PDF

Carotid-cavernous fistula due to contralateral orbital trauma.

Oman J Ophthalmol

October 2024

Department of Imaging Sciences and Interventional Radiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India.

Direct carotid cavernous fistula is an abnormal arterio-venous connection from the carotid artery to the cavernous sinus (CS), resulting in high-pressure arterial blood entering the low-pressure venous CS. Most often, it occurs posttrauma and presents with ipsilateral orbital signs. In this report, we describe the case of a 54-year-old man, who presented with a late-onset right-sided red eye and diplopia following contralateral (left sided) orbital trauma (road traffic accident 7 months ago).

View Article and Find Full Text PDF

Rheumatoid Arthritis: A Rare Cause of Pachymeningitis and Optic Neuritis.

Eur J Case Rep Intern Med

November 2024

Department of Internal Medicine, Tower Health, Reading Hospital, West Reading, USA.

Introduction: Rheumatoid pachymeningitis and optic neuritis are rare complications of rheumatoid arthritis (RA) and are a diagnosis of exclusion.

Case Description: A 75-year-old male with a history of seronegative RA presented to the emergency department with left eye pain and blurry vision lasting two days. He had been diagnosed with seronegative RA around nine months previously.

View Article and Find Full Text PDF

Purpose: This study aimed to identify the various clinical characteristics and ocular imaging features of ocular toxoplasmosis (OT) in HIV patients.

Methods: Observational retrospective study of 52 eyes of 38 HIV patients with OT.

Results: 68% of patients were male.

View Article and Find Full Text PDF

Difluprednate (DFP) (difluoroprednisolone butyrate acetate, or DFBA) ophthalmic emulsion 0.05% (Durezol®) was the first potent corticosteroid to be approved for both postoperative pain and inflammation in 2008. In June 2012, it was approved for the treatment of endogenous anterior uveitis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!